ARTICLE | Clinical News
Doryx doxycycline hyclate delayed-release tablet regulatory update
April 22, 2013 7:00 AM UTC
FDA approved a 200 mg dose of tetracycline oral antibiotic Doryx doxycycline hyclate delayed-release tablet from Mayne's U.S. marketing partner Warner Chilcott plc (NASDAQ:WCRX, Dublin, Ireland). War...